Home > Compound List > Product Information
1-Boc-4-(aminomethyl)piperidine_Molecular_structure_CAS_144222-22-0)
Click picture or here to close

1-Boc-4-(aminomethyl)piperidine

Catalog No. 641472 Name Sigma Aldrich
CAS Number 144222-22-0 Website http://www.sigmaaldrich.com
M. F. C11H22N2O2 Telephone 1-800-521-8956
M. W. 214.30458 Fax
Purity 97% Email
Storage Chembase ID: 34839

SYNONYMS

Title
1-Boc-4-(氨基甲基)哌啶
IUPAC name
tert-butyl 4-(aminomethyl)piperidine-1-carboxylate
IUPAC Traditional name
tert-butyl 4-(aminomethyl)piperidine-1-carboxylate
Synonyms
N-(tert-Butoxycarbonyl)-4-aminomethylpiperidine
1,1-Dimethylethyl 4-(aminomethyl)-1-piperidinecarboxylate

DATABASE IDS

PubChem SID 24883120
MDL Number MFCD01076207
CAS Number 144222-22-0

PROPERTIES

Empirical Formula (Hill Notation) C11H22N2O2
Purity 97%
Boiling Point 237-238 °C(lit.)
Density 1.013 g/mL at 25 °C(lit.)
Flash Point >110 °C
Flash Point >230 °F
Refractive Index n20/D 1.473(lit.)
GHS Pictograms GHS07
GHS Pictograms GHS09
GHS Signal Word Warning
GHS Hazard statements H315-H319-H335-H400
European Hazard Symbols Irritant Irritant (Xi)
European Hazard Symbols Nature polluting Nature polluting (N)
MSDS Link Download
Personal Protective Equipment Eyeshields, full-face respirator (US), Gloves, multi-purpose combination respirator cartridge (US), type ABEK (EN14387) respirator filter
GHS Precautionary statements P261-P273-P305 + P351 + P338
Risk Statements 36/37/38-50
Safety Statements 26-36-61
German water hazard class 3

DETAILS

Description (English)
Packaging
5, 25 g in glass bottle
Application
Precursor in the preparation of a variety of different protein agonists or antagonists including:
• Kinesin spindle protein inhibitors with potential anticancer activity1
• Orphan G-protein coupled receptor GPR119 agonist with antidiabetic potential2
• Pim-1 inhibitors3
• Aspartic acid protease inhibitors4Reactant involved in enantioselective synthesis of N-alkyl terminal aziridines5
Description (简体中文)
包装
5, 25 g in glass bottle
Application
Precursor in the preparation of a variety of different protein agonists or antagonists including:
• Kinesin spindle protein inhibitors with potential anticancer activity1
• Orphan G-protein coupled receptor GPR119 agonist with antidiabetic potential2
• Pim-1 inhibitors3
• Aspartic acid protease inhibitors4Reactant involved in enantioselective synthesis of N-alkyl terminal aziridines5

REFERENCES